Your shopping cart is currently empty

BRD4 D1-IN-3 (compound 39) is a potent and highly selective BRD4-D1 inhibitor, exhibiting cellular activity with an IC50 of 39 nM and a Ki of 2.4 nM, and demonstrating over 1700-fold selectivity against BRD2-D1. In LPS-mediated liver inflammation cell models, BRD4 D1-IN-3 reduces the expression of pro-inflammatory chemokines CXCL1 and CCL2. This compound is applicable in studies of liver inflammation.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BRD4 D1-IN-3 (compound 39) is a potent and highly selective BRD4-D1 inhibitor, exhibiting cellular activity with an IC50 of 39 nM and a Ki of 2.4 nM, and demonstrating over 1700-fold selectivity against BRD2-D1. In LPS-mediated liver inflammation cell models, BRD4 D1-IN-3 reduces the expression of pro-inflammatory chemokines CXCL1 and CCL2. This compound is applicable in studies of liver inflammation. |
| Targets&IC50 | BRD4 BD1:39 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.